Send a Tweet
Most Popular Choices
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Tell A Friend Printer Friendly Page Save As Favorite View Favorites
Exclusive to OpEdNews:
OpEdNews Op Eds

Capitalism and AIDS

By       Message Donald de Fano       (Page 1 of 1 pages)     Permalink    (# of views)   1 comment

Related Topic(s): ; ; ; ; , Add Tags
Add to My Group(s)

View Ratings | Rate It

Author 30599
- Advertisement -

When President Obama dismissed his Progressive critics by asserting that the public option was of little significance in the larger scheme of health insurance reform, and when the backroom deal was struck with the pharmaceutical industry that in return for their domestic support healthcare reform would prohibit purchase of less expensive drugs from Canada, it was clear that in his mind availability of health services trumped accessibility of health services.   Such a view is entirely consistent with the principles of capitalism: you can have the best health care in the world as long as you can afford to pay for it. 

This week's news is filled with hope that a recent study published by the New England Journal of Medicine will be a significant step in the fight against AIDS.   A key drug in this effort   is a product produced by Gilead   with the trade name Truvada.   The drug itself is not new, but its application as an AIDS preventative is.   The catch is that it's expensive.   Business Week puts the cost of Truvada between   "$5,000 and $7,000 a year in the U.S. when bought through the health-care system, and more if bought privately."   The New York Times puts the cost at "$12,000 to $14,000 a year."  

In 2005, Gilead announced Truvada would be made available to developing third world countries at a before profit cost of $.87 per day.  The New York Times, in its article, observes that "[i]n very poor countries, generic versions cost as little as 40 cents a pill."   Thus, taking the most conservative numbers, the annual   before profit cost of Truvana would be less than $500 a year, and the after profit cost would be at least $5000 a year for American buyers, an overhead spread of 1000 per cent. 

It would seem that Progressives have a point.   If the moral imperative to provide needed medication to third world countries is so obvious that the profit motive is cast aside in the interest of human need, what is the domestic justification for denying that medication to Americans who can't afford it?   Is this not in fact a demonstration that in matters of public health, the application of capitalistic principles is inappropriate?     Public health should be decoupled from private profit.

- Advertisement -



- Advertisement -

View Ratings | Rate It

I am a retired boatbuilder with a fascination for political thought. Most of my life I cheerfully described myself as an "eastern establishment, knee jerk, liberal Democrat."

Donald de Fano Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter
   (Opens new browser window)

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Capitalism and Health Care

Corporate America's Secret Weapon: Socialism

The Occupation is the Message

Follow the Money

A Pol Meets a Senator

A Case Study: Dawn E. Johnsen